Live demo · no account

Calibrated on 1,601 real IBM Heron jobs — not simulation.

Fold a target.
Make a candidate.
Score the binding.

One drug-discovery run you can open and check — four saved steps: fold, candidate, binding, genomic check. NVIDIA models handle structure and candidates. Every workload is routed through a calibrated, qubit-aware router trained on 1,601 real IBM Heron jobs. If a job needs real quantum capacity, it goes to a quantum backend. You never compile a circuit or figure out the qubit threshold yourself.

Fold Candidate Binding Genomic check
Partners
MGM University

01 Fold the target

Step 1 of 4 · structure
Boltz-2 structure of the target — mean pLDDT 94.46 over 65 residues
Real fold · Boltz-2
3D fold
drag to rotate
high B-factor low B-factor
Reference · interactive view
RCSB 1M17 · EGFR kinase domain

RCSB 1M17 is a reference render for the interactive view — not a claim that this browser panel ran the live fold. Drag to rotate.

How it works

Four steps.
Open them.
Check them.

A full discovery pass from structure to a binding score — saved so your team can review every step before anyone touches a bench.

Where the value is

Calibrated router into Fold, Candidate, Binding, and Genomic check — each step sealed by default

Value is the routed path, the four inspectable steps, and the sealed trail your team can check.

  1. Fold the target

    Build a 3D structure of the protein you care about, so later steps work from a real shape — not a guess.

  2. Make a candidate

    Propose a small molecule aimed at that fold. You see what was suggested and how it sits in the pocket.

  3. Score the binding

    Estimate how well the candidate may bind. Predicted — not a wet-lab measurement.

  4. Genomic check

    Cross-check the target against genomic context so the run stays grounded in biology your team already trusts.

Built for audit

Every step
gets sealed.

Every step is sealed as it runs — signature and watermark on by default, written to a tamper-evident record for compliance and audit. Sealing happens at the model layer, with post-quantum cryptography. A third party can verify it without taking our word for it. You never have to turn that on; it’s enforced by default.

Two ways in

Discovery or trial.

Kill the bad molecule early.

Screen out non-starters before they burn years and budget.

Open Quantum Pharma →

Design the trial. Carry the dossier.

Size the study, pick the right patients, keep the IND trail intact.

Open Quantum Rx →

Who it’s for

R&D labs.
Built to be checked.

Built for biotech and discovery teams that need a run they can open and argue with. Not for clinical care or patient decisions.

  • Discovery and computational chemistry groups evaluating new targets
  • Biotech R&D leads who want a fold-to-binding trail before wet-lab spend
  • Partner teams that need a shared, inspectable run — not a black box

What you can do today

Look first.
Or send a target.

Open the live run

Walk the saved fold, candidate, binding, and genomic check in your browser. No signup.

Open the live run

Send us a target

Tell us the protein you care about. We hand-run a discovery pass and return a link your team can open.

Send us a target

See a full discovery run

Open the live demo now, or email a target and we will run it for you.